Patent · US Active

Methods for treating inflammatory conditions

US9408844B2 · kind B2 · utility

0Cited by
1References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 17, 2014
Grant dateAug 9, 2016
Priority date
Expiry dateApr 17, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2800/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising tenilsetam or pharmaceutically acceptable salts thereof that are useful in modulating inflammation. In particular, the compounds or pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder involving inflammation, including, but not limited to, delayed type hypersensitivity and contact hypersensitivity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.